Fulford India jumps 20 pc on Merck & Co's delisting offer

Fulford India Ltd, a domestic subsidiary of Merck & Co Inc, jumped 20 per cent to its maximum daily limit, after it approved a delisting offer from its parent company

Merck is offering an indicative price of 1,150 rupees per share, a 67.7 percent premium to Fulford India's Friday's close, with the floor price set at 701.71 rupees, according to the BSE filing.

Merck & Co owns 74.95 percent stake in Fulford, and is looking to acquire the remaining 25.05 percent.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Regional parties that brought diversity to Indian democracy are at a dead end

    In the two decades, which began in 1989, when the paradigm of coalition politics came to dominate central governments, it would have sounded far-fetch

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

Sustainable model for rural sanitation

Prime minister Narendra Modi has promised to build a toilet ...

Kuruvilla Pandikattu SJ

What we can learn from agnosticism

As an agnostic, the American writer David Breeden is aware ...

Shona Adhikari

When women to birds become a painter’s muses

This week the focus is on renowned artist Amitabha Banerjee, ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture